pipamperone has been researched along with Alzheimer Disease in 1 studies
pipamperone: RN given refers to parent cpd; structure
pipamperone : A member of the class of bipiperidines that is 1,4'-bipiperidine which is substituted at the 1' and 4' positions by 4-(p-fluorophenyl)-4-oxobutyl and carboxamide groups, respectively. A first generation antipsychotic, its properties are generally similar to those of haloperidol.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypothermia is a potentially life-threatening side effect of antipsychotic drugs, especially those with strong 5-HT2 antagonist properties." | 5.43 | Reversible Hypothermia in a Drug-naive Inpatient with Alzheimer's Disease Receiving Pipamperone. ( Kamp, D; Lange-Asschenfeldt, C; Paschali, M, 2016) |
| "Hypothermia is a potentially life-threatening side effect of antipsychotic drugs, especially those with strong 5-HT2 antagonist properties." | 1.43 | Reversible Hypothermia in a Drug-naive Inpatient with Alzheimer's Disease Receiving Pipamperone. ( Kamp, D; Lange-Asschenfeldt, C; Paschali, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamp, D | 1 |
| Paschali, M | 1 |
| Lange-Asschenfeldt, C | 1 |
1 other study available for pipamperone and Alzheimer Disease
| Article | Year |
|---|---|
Reversible Hypothermia in a Drug-naive Inpatient with Alzheimer's Disease Receiving Pipamperone.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Butyrophenones; Female; Humans; Hypothermia | 2016 |